Grassi F, Meneveri R, Gullberg M, Lopalco L, Rossi G B, Lanza P, De Santis C, Brattsand G, Buttò S, Ginelli E
Dipartimento di Biologia e Genetica per le Scienze Mediche, Università di Milano, Italy.
J Exp Med. 1991 Jul 1;174(1):53-62. doi: 10.1084/jem.174.1.53.
Murine monoclonal antibodies (mAbs) M38 and L31 define two epitopes of a surface protein of activated lymphocytes and monocytes. It has been shown that M38 also defines a crossreactive epitope of human immunodeficiency virus type 1 (HIV-1) gp120 (Beretta et al., 1987. Eur. J. Immunol. 17: 1793). The mAb inhibits syncytia formation driven by HIV-1-infected cells. The surface protein was demonstrated to be a class I MHC alpha chain, by sequence analysis of the corresponding cDNA and by immunological means. The epitopes defined by mAbs M38 and L31 are monomorphic and hidden (i.e., inaccessible to antibodies) on native HLA molecules expressed by resting cells, but can be evidenced on denatured proteins by Western blot analysis. The two epitopes become accessible after activation processes have been implemented, likely reflecting a conformational alteration of alpha chains (such as that described by Schnabl et al. 1990. J. Exp. Med. 171:1431). Consistent with molecular data are the results of functional analysis, which indicate that the molecule recognized by M38 and L31 is a gate for pleiotropic negative signals, since the two mAbs were shown to inhibit monocyte antigen presentation and lymphocyte mitogenic proliferation, respectively.
鼠单克隆抗体(mAb)M38和L31确定了活化淋巴细胞和单核细胞表面蛋白的两个表位。研究表明,M38还确定了人类免疫缺陷病毒1型(HIV-1)gp120的一个交叉反应表位(贝雷塔等人,1987年。《欧洲免疫学杂志》17:1793)。该单克隆抗体抑制HIV-1感染细胞驱动的合胞体形成。通过对相应cDNA的序列分析和免疫学方法,证明该表面蛋白是I类MHCα链。mAb M38和L31确定的表位在静息细胞表达的天然HLA分子上是单态且隐藏的(即抗体无法接近),但通过蛋白质印迹分析可在变性蛋白上得到证实。在实施激活过程后,这两个表位变得可接近,这可能反映了α链的构象改变(如施纳布尔等人1990年在《实验医学杂志》171:1431中所描述的那样)。功能分析结果与分子数据一致,表明M38和L31识别的分子是多效性负信号的一个通道,因为这两种单克隆抗体分别被证明可抑制单核细胞抗原呈递和淋巴细胞有丝分裂增殖。